| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
350.50 |
| Sales(₹ Cr.) |
10,788.09 |
NP (₹ Cr.) |
1,746.79 |
| NP Var% |
-11.00 |
Div% |
0.00 |
| CPS(₹) |
34.90 |
EPS (₹) |
29.80 |
| Traded Value(₹ Lakhs) |
883.44 |
52 Week High |
1,593.00 |
| 52 Week Low |
994.00 |
Price BSE |
1,123.00 |
| Price NSE |
1,123.00 |
Market Capital (₹ Cr.) |
65,809.69 |
| P/C Ratio |
32.20 |
P/E Ratio |
37.70 |
| Price Vs.BV |
3.20 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
2,721.43 |
| NP(₹ Cr.) |
408.17 |
NP Var % |
-29.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
10,713.37 |
| OPM |
23.11 |
NP |
2,069.02 |
| NP Var% |
-10.56 |
EPS |
29.81 |
| PE |
37.68 |
|
|